Jeanne Marie Lecomte

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Bioprojet, National Institute of Health and Medical Research, Societe Civile Bioprojet. Active years: 1994-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeanne Marie Lecomte. Retrieved from https://idiyas.com/inventor/jeanne-marie-lecomte-rfg7dohx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 3

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

National Institute of Health and Medical Research

patents

1 out of 20

Societe Civile Bioprojet

patents

where one patent can have more than one assignee

Years Active: 1994-2024

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12059416 - Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof (2024-08-13),

2. 11229632 - Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof (2022-01-25),

3. 5321039 - Method of inducing a histamine agonist action on H.sub.2 receptors (1994-06-14),

Title: Jeanne Marie Lecomte: Innovator in Therapeutic Combinations

Introduction

Jeanne Marie Lecomte is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmacology, particularly in the development of therapeutic combinations that enhance wake-promoting activities. With a total of 3 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Among her latest patents are innovative combinations of a H3 antagonist and a noradrenaline reuptake inhibitor. These combinations are designed to exhibit synergistic wake-promoting activity, which can be beneficial in treating conditions such as depression. The patents disclose the therapeutic uses of these combinations, highlighting their potential in enhancing patient outcomes.

Career Highlights

Jeanne has worked with notable companies in the pharmaceutical sector, including Bioprojet and Société Civile Bioprojet. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects that aim to improve mental health treatments.

Collaborations

Throughout her career, Jeanne has collaborated with esteemed colleagues such as Jean Charles Schwartz and Xavier Ligneau. These partnerships have contributed to her success and the advancement of her innovative ideas in the field.

Conclusion

Jeanne Marie Lecomte's work in developing therapeutic combinations showcases her dedication to improving mental health treatments. Her patents reflect her innovative spirit and commitment to advancing pharmacological research.

Profile summary based on public USPTO records.